| 11/12/2026 11:15 PM | Cyclacel Pharmaceuticals (1130166) Filer | Form EFFECT | |
| 11/12/2026 4:20 PM | Cyclacel Pharmaceuticals (1130166) Filer | Form 424B3 | |
| 11/12/2026 4:00 PM | Cyclacel Pharmaceuticals (1130166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/12/2026 3:45 PM | Cyclacel Pharmaceuticals (1130166) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/04/2026 4:28 PM | Cyclacel Pharmaceuticals (1130166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/23/2026 3:05 PM | Cyclacel Pharmaceuticals (1130166) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 10/16/2026 3:05 PM | Cyclacel Pharmaceuticals (1130166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/09/2026 3:05 PM | Cyclacel Pharmaceuticals (1130166) Filer | Form 424B3 | |
| 10/08/2026 11:15 PM | Cyclacel Pharmaceuticals (1130166) Filer | Form EFFECT | |
| 08/21/2026 3:12 PM | Cyclacel Pharmaceuticals (1130166) Filer | Form S-4/A | |
| 08/13/2026 8:37 PM | Cyclacel Pharmaceuticals (1130166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for BGMS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
| 08/12/2026 8:12 PM | Cyclacel Pharmaceuticals (1130166) Subject Yap Kim Choy (2081554) Filed by | Form SCHEDULE 13G/A | |
| 08/12/2026 8:14 PM | Cyclacel Pharmaceuticals (1130166) Subject FITTERS Diversified Berhad (2086215) Filed by | Form SCHEDULE 13G/A | |
| 07/01/2026 3:05 PM | Cyclacel Pharmaceuticals (1130166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/22/2026 5:10 AM | Cyclacel Pharmaceuticals (1130166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/10/2026 11:47 AM | Cyclacel Pharmaceuticals (1130166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/04/2026 3:45 PM | Cyclacel Pharmaceuticals (1130166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/04/2026 3:47 PM | Cyclacel Pharmaceuticals (1130166) Subject | Form 425 | |
| 05/12/2026 4:58 PM | Cyclacel Pharmaceuticals (1130166) Subject Yap Kim Choy (2081554) Filed by | Form SCHEDULE 13G/A | |
| 04/27/2026 3:38 PM | Cyclacel Pharmaceuticals (1130166) Filer | Form DEF 14A | |
| 04/13/2026 10:51 AM | Cyclacel Pharmaceuticals (1130166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/13/2026 11:34 AM | Cyclacel Pharmaceuticals (1130166) Subject Ong Yee Lung (2081473) Filed by | Form SCHEDULE 13G/A | |
| 03/13/2026 11:26 AM | Cyclacel Pharmaceuticals (1130166) Subject Kua Khai Loon (2081556) Filed by | Form SCHEDULE 13G/A | |
| 03/13/2026 9:30 AM | Cyclacel Pharmaceuticals (1130166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/12/2026 3:05 PM | Cyclacel Pharmaceuticals (1130166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/28/2025 3:59 PM | Cyclacel Pharmaceuticals (1130166) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 11/26/2025 4:01 PM | Cyclacel Pharmaceuticals (1130166) Filer | Form 10-K/A | |